Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies

English version České info

Background:
Genetic and epidemiological evidence suggests an inverse association between B-type natriuretic peptide (BNP) levels in blood and risk of type 2 diabetes (T2D), but the prospective association of BNP with T2D is uncertain, and it is unclear whether the association is confounded.

Methods and Findings:
We analysed the association between levels of the N-terminal fragment of pro-BNP (NT-pro-BNP) in blood and risk of incident T2D in a prospective case-cohort study and genotyped the variant rs198389 within the BNP locus in three T2D case-control studies. We combined our results with existing data in a meta-analysis of 11 case-control studies. Using a Mendelian randomization approach, we compared the observed association between rs198389 and T2D to that expected from the NT-pro-BNP level to T2D association and the NT-pro-BNP difference per C allele of rs198389. In participants of our case-cohort study who were free of T2D and cardiovascular disease at baseline, we observed a 21% (95% CI 3%–36%) decreased risk of incident T2D per one standard deviation (SD) higher log-transformed NT-pro-BNP levels in analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking, family history of T2D, history of hypertension, and levels of triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. The association between rs198389 and T2D observed in case-control studies (odds ratio = 0.94 per C allele, 95% CI 0.91–0.97) was similar to that expected (0.96, 0.93–0.98) based on the pooled estimate for the log-NT-pro-BNP level to T2D association derived from a meta-analysis of our study and published data (hazard ratio = 0.82 per SD, 0.74–0.90) and the difference in NT-pro-BNP levels (0.22 SD, 0.15–0.29) per C allele of rs198389. No significant associations were observed between the rs198389 genotype and potential confounders.

Conclusions:
Our results provide evidence for a potential causal role of the BNP system in the aetiology of T2D. Further studies are needed to investigate the mechanisms underlying this association and possibilities for preventive interventions.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies. PLoS Med 8(10): e32767. doi:10.1371/journal.pmed.1001112
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001112

Souhrn

Zdroje

1. PotterLRYoderARFloraDRAntosLKDickeyDM 2009 Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 341 366

2. SengenesCBerlanMde GlisezinskiILafontanMGalitzkyJ 2000 Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14 1345 1351

3. WangTJLarsonMGLevyDBenjaminEJLeipEP 2004 Impact of obesity on plasma natriuretic peptide levels. Circulation 109 594 600

4. WangTJLarsonMGKeyesMJLevyDBenjaminEJ 2007 Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115 1345 1353

5. MeirhaegheASandhuMSMcCarthyMIde GrootePCottelD 2007 Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 16 1343 1350

6. Newton-ChehCLarsonMGVasanRSLevyDBlochKD 2009 Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 41 348 353

7. HalbirkMNorrelundHMollerNSchmitzOBotkerHE 2010 Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. Int J Cardiol 144 140 142

8. Chainani-WuNWeidnerGPurnellDMFrendaSMerritt-WordenT 2010 Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes. Am J Cardiol 105 1570 1576

9. van KimmenadeRvan DielenFBakkerJNijhuisJCrijnsH 2006 Is brain natriuretic peptide production decreased in obese subjects? J Am Coll Cardiol 47 886 887

10. TaylorJAChristensonRHRaoKJorgeMGottliebSS 2006 B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 152 1071 1076

11. SalomaaVHavulinnaASaarelaOZellerTJousilahtiP 2010 Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS ONE 5 e10100 doi:10.1371/journal.pone.0010100

12. HalsallDJMcFarlaneILuanJCoxTMWarehamNJ 2003 Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study. Hum Mol Genet 12 1361 1365

13. LauritzenTGriffinSBorch-JohnsenKWarehamNJWolffenbuttelBH 2000 The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 24 Suppl 3 S6 S11

14. LoosRJFranksPWFrancisRWBarrosoIGribbleFM 2007 TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56 1943 1947

15. VoightBFScottLJSteinthorsdottirVMorrisAPDinaC 2010 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42 579 589

16. DayNOakesSLubenRKhawKTBinghamS 1999 EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 Suppl 1 95 103

17. KhawKTWarehamNBinghamSLubenRWelchA 2004 Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141 413 420

18. McFaddenELubenRWarehamNBinghamSKhawKT 2008 Occupational social class, educational level, smoking and body mass index, and cause-specific mortality in men and women: a prospective study in the European Prospective Investigation of Cancer and Nutrition in Norfolk (EPIC-Norfolk) cohort. Eur J Epidemiol 23 511 522

19. ChoquetHCavalcanti-ProencaCLecoeurCDinaCCauchiS 2009 The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 18 2495 2501

20. Onland-MoretNCvan der ADLvan der SchouwYTBuschersWEliasSG 2007 Analysis of case-cohort data: a comparison of different methods. J Clin Epidemiol 60 350 355

21. TakeishiYToriyamaSTakabatakeNShibataYKontaT 2007 Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. Biochem Biophys Res Commun 362 480 484

22. LanfearDEStolkerJMMarshSRichMWMcLeodHL 2007 Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 21 55 62

23. DidelezVSheehanN 2007 Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16 309 330

24. ThomasDCLawlorDAThompsonJR 2007 Re: Estimation of bias in nongenetic observational studies using “Mendelian triangulation” by Bautista, et al. Ann Epidemiol 17 511 513

25. De SilvaNMFreathyRMPalmerTMDonnellyLALuanJ 2011 Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes 60 1008 1018

26. WangTJLevyDBenjaminEJVasanRS 2003 The epidemiology of “asymptomatic” left ventricular systolic dysfunction: implications for screening. Ann Intern Med 138 907 916

27. TabakAGJokelaMAkbaralyTNBrunnerEJKivimakiM 2009 Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373 2215 2221

28. MiyashitaKItohHTsujimotoHTamuraNFukunagaY 2009 Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58 2880 2892

29. SorianoSRoperoABAlonso-MagdalenaPRipollCQuesadaI 2009 Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol Endocrinol 23 1973 1982

30. RoperoABSorianoSTuduriEMarroquiLTellezN 2010 The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. Endocrinology 151 3665 3674

31. HuangWSLeeMSPerngHWYangSPKuoSW 2002 Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 51 1423 1426

32. MohammedSFKorinekJChenHHBurnettJCRedfieldMM 2008 Nesiritide in acute decompensated heart failure: current status and future perspectives. Rev Cardiovasc Med 9 151 158

33. RitchieRHRosenkranzACKayeDM 2009 B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med 9 814 825